You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
SUREPATH PAP |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: Screen: LAB4102. Diagnostic: LAB4103 Geisinger Epic ID: Screen 19360. Diagnostic 19376 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Gynecologic specimen (cervical screening) | |
Preferred collection container: |
||
Specimen required: |
SurePath vial of preservative fluid with collection device submitted in vial. | |
Special notes: |
The cervical transition zone is sampled with the SurePath broom (long tines inserted into the cervical os and the broom twisted clockwise 4 times). The broom tip is then "popped off" the sample handle into the SurePath vial with preservative solution. The vial (with solution AND broom tip) is labeled with patient name and medical record number prior to submission to the laboratory. | |
Patient preparation: |
No vaginal lubricants to be utilized prior to collection of thin-layer specimen. | |
| SPECIMEN PROCESSING |
||
Transport temperature: |
Room temperature. | |
Rejection criteria: |
Inadequate patient identifiers on specimen, unlabeled specimen, discrepancy between patient specimen and requisition information, improper collection. | |
TEST DETAILS |
||
CPT code(s): |
88142 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Microscopic examination of Pap-stained thin-layer specimen. | |
Methodology: |
Microscopic Examination |
|
Synonyms: |
Pap, Thin Layer, Liquid-Based Pap, SurePath Cytology, Pap Screen, Pap Diagnostic TriPath, Cervical screening, Vaginal screening
|
|
Clinical significance: |
Cervical screening for the detection of premalignant or malignant lesions of the cervix which can be eradicated, thus reducing the occurrence of carcinoma of the cervix. | |
Doctoral Director(s:) |
Sara Monaco MD | |
| Review Date: | 12/23/2022 | |